<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Goncalves MG</submitter><pubmed_abstract>Brazil currently has the highest number of individuals infected with human T-lymphotropic virus 1- and 2- (HTLV-1 and HTLV-2) globally. At present, neither molecular protocols nor commercial assays are available for HTLV-1/-2 diagnosis or validated by the Brazilian Ministry of Health regulatory agency (ANVISA). We developed and validated two in-house multiplex quantitative real-time PCR for HTLV-1/-2 (mqPCR_HTLV) assays, targeting the &lt;i>pol&lt;/i> and &lt;i>tax&lt;/i> genes, for the simultaneous identification of HTLV-1, HTLV-2, and the albumin reference gene. The robustness of the assays was evaluated on two platforms using seven commercial master mix formulations. The reactions employed double plasmids (pHTLV1-Alb and pHTLV2-Alb) for the standard curve's construction and for expressing the detec</pubmed_abstract><journal>Frontiers in microbiology</journal><pagination>831594</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8965094</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Development and Validation of Multiplex Quantitative Real-Time PCR Assays for Simultaneous Detection and Differentiation of HTLV-1 and HTLV-2, Using Different PCR Platforms and Reagent Brands.</pubmed_title><pmcid>PMC8965094</pmcid><pubmed_authors>Campos KR</pubmed_authors><pubmed_authors>Fukasawa LO</pubmed_authors><pubmed_authors>Caterino-de-Araujo A</pubmed_authors><pubmed_authors>Higa FT</pubmed_authors><pubmed_authors>Goncalves MG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development and Validation of Multiplex Quantitative Real-Time PCR Assays for Simultaneous Detection and Differentiation of HTLV-1 and HTLV-2, Using Different PCR Platforms and Reagent Brands.</name><description>Brazil currently has the highest number of individuals infected with human T-lymphotropic virus 1- and 2- (HTLV-1 and HTLV-2) globally. At present, neither molecular protocols nor commercial assays are available for HTLV-1/-2 diagnosis or validated by the Brazilian Ministry of Health regulatory agency (ANVISA). We developed and validated two in-house multiplex quantitative real-time PCR for HTLV-1/-2 (mqPCR_HTLV) assays, targeting the &lt;i>pol&lt;/i> and &lt;i>tax&lt;/i> genes, for the simultaneous identification of HTLV-1, HTLV-2, and the albumin reference gene. The robustness of the assays was evaluated on two platforms using seven commercial master mix formulations. The reactions employed double plasmids (pHTLV1-Alb and pHTLV2-Alb) for the standard curve's construction and for expressing the detec</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-05-31T06:04:12.429Z</modification><creation>2025-02-19T01:55:12.05Z</creation></dates><accession>S-EPMC8965094</accession><cross_references><pubmed>35369428</pubmed><doi>10.3389/fmicb.2022.831594</doi></cross_references></HashMap>